Darryl has deep expertise in molecular biology, neuroscience, and genetics in psychedelics. He holds a PhD in molecular biology and genetics. Prior to founding GoodCap, Darryl co-founded InPlanta Biotechnology Inc. and Pathways Rx, where he led the development and commercialization of proprietary plant genetics. He has also co-authored numerous peer-reviewed research articles on plant biology, genetics, DNA repair, epigenetics, and cancer.
